Compare ATKR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATKR | ADMA |
|---|---|---|
| Founded | 1959 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2016 | 2012 |
| Metric | ATKR | ADMA |
|---|---|---|
| Price | $75.37 | $8.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $75.67 | $25.67 |
| AVG Volume (30 Days) | 268.9K | ★ 2.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | ★ $2,850,378,000.00 | $42,219,783.00 |
| Revenue This Year | $6.55 | $27.46 |
| Revenue Next Year | $3.89 | $22.11 |
| P/E Ratio | ★ N/A | $44.63 |
| Revenue Growth | N/A | ★ 43.85 |
| 52 Week Low | $53.49 | $7.21 |
| 52 Week High | $90.16 | $20.46 |
| Indicator | ATKR | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 51.52 |
| Support Level | $68.88 | $7.38 |
| Resistance Level | $79.03 | $8.97 |
| Average True Range (ATR) | 2.45 | 0.26 |
| MACD | 0.52 | -0.04 |
| Stochastic Oscillator | 75.31 | 48.07 |
Atkore Inc is a manufacturer of Electrical products for the non-residential construction and renovation markets, as well as residential markets, and Safety & Infrastructure products for the construction and industrial markets. The Electrical segment manufactures products used in the construction of electrical power systems including conduit, cable, and installation accessories. This segment serves contractors in partnership with the electrical wholesale channel. The Safety & Infrastructure segment designs and manufactures solutions including metal framing, mechanical pipe, perimeter security, and cable management. These solutions are marketed to contractors, original equipment manufacturers (OEMs), and end-users. The majority of revenue is generated from the Electrical segment.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.